Phio Pharmaceuticals Corp logo

Phio Pharmaceuticals Corp

$ 0.56 -0.0255 (-4.37%) 10:08 PM EST
P/E:
At Loss
P/B:
0.45
Market Cap:
$ 7.62M
Enterprise V:
$ -9.81M
Volume:
195.96K
Avg Vol (2M):
88.11K
Also Trade In:
Volume:
195.96K
Market Cap $:
7.62M
PE Ratio:
At Loss
Avg Vol (2-Month):
88.11K
Enterprise Value $:
-9.81M
PB Ratio:
0.45
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 77.01
Equity-to-Asset 0.84
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.95
9-Day RSI 27.95
14-Day RSI 31.67
6-1 Month Momentum % -24.8
12-1 Month Momentum % -63.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.48
Quick Ratio 6.48
Cash Ratio 5.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -240.6

Financials (Next Earnings Date:2022-11-15 Est.)

PHIO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PHIO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.92
Beta 1.46
Volatility % 35.38
14-Day RSI 31.67
14-Day ATR ($) 0.042389
20-Day SMA ($) 0.652455
12-1 Month Momentum % -63.75
52-Week Range ($) 0.5475 - 2.42
Shares Outstanding (Mil) 13.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Phio Pharmaceuticals Corp Filings

Document Form Filing Date
No Filing Data

Phio Pharmaceuticals Corp Analysis

Share your research

Headlines

See More
No news.